Lannett Company Inc (NYSE:LCI)

66.15
BATS BZX Real-Time Price
As of 11:23am ET
 -1.56 / -2.30%
Today’s Change
29.12
Today|||52-Week Range
71.26
+54.27%
Year-to-Date
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Adds 5.4% - Tale of the Tape
9:58am / Zacks.com
Pfizer & Eli Lilly to Resume Phase III Study of Tanezumab - Analyst Blog
Mar 24 / Zacks.com
BioDelivery Slumps, Diabetic Pain Gel Fails Phase III Study - Analyst Blog
Mar 31 / Zacks.com
Calithera Biosciences (CALA) Jumps: Stock Rises 19% - Tale of the Tape
Mar 24 / Zacks.com
Novartis Gets FDA Approval for Oral Formulation of Exjade - Analyst Blog
Mar 31 / Zacks.com
Amgen Seeks Approval for PCSK9 Inhibitor Repatha in Japan - Analyst Blog
Mar 23 / Zacks.com
The Medicines Co.'s 3 Acute Care Drugs Approved in EU - Analyst Blog
Mar 31 / Zacks.com
Novartis Reports Positive Data on Psoriasis Drug Cosentyx - Analyst Blog
Mar 23 / Zacks.com
7 Picks For Successful ETF Investing
Mar 30 / Investing Channel
Coronado Biosciences Jumps on Agreement with NeuPharma - Analyst Blog
Mar 20 / Zacks.com
Conatus Soars on Positive Phase II Data on Emricasan - Analyst Blog
Mar 27 / Zacks.com
Concert Pharmaceuticals (CNCE) in Focus: Stock Tumbles 10.8% - Tale of the Tape
Mar 20 / Zacks.com
Calithera Biosciences (CALA) Crumbles: Stock Falls by 7.3% - Tale of the Tape
Mar 27 / Zacks.com
Tetraphase Closes Public Offering, to Raise $173.1M - Analyst Blog
Mar 19 / Zacks.com
Agios' PK Deficiency Drug AG-348 Gets Orphan Drug Status - Analyst Blog
Mar 26 / Zacks.com
Vertex's Kalydeco Gets FDA Nod for Additional Indication - Analyst Blog
Mar 19 / Zacks.com
Vical In-Licenses Antifungal Drug ASP2397 from Astellas - Analyst Blog
Mar 26 / Zacks.com
Retrophin Soars on FDA Approval of Bile Acid Disorder Drug - Analyst Blog
Mar 19 / Zacks.com
Oncolytics' Cancer Drug Reolysin Gets Orphan Status in EU - Analyst Blog
Mar 26 / Zacks.com
Aldeyra Initiates Phase II Sjogren-Larsson Syndrome Study - Analyst Blog
Mar 19 / Zacks.com
ZS Pharma (ZSPH) Crumbles: Stock Falls by 9.9% - Tale of the Tape
Mar 26 / Zacks.com
Celldex, Roche Ink Deal to Develop Kidney Cancer Drug - Analyst Blog
Mar 18 / Zacks.com
Weakness Seen in Sage Therapeutics (SAGE): Stock Falls 13.2% - Tale of the Tape
Mar 26 / Zacks.com
Esperion Soars on Positive Phase IIb Data on ETC-1002 - Analyst Blog
Mar 18 / Zacks.com
OvaScience, Fred's, Weight Watchers Lead Wednesday's After-Hours Movers
Mar 25 / Benzinga
Onconova Therapeutics, Inc. (ONTX) Rises: Stock Up 11.4% - Tale of the Tape
Mar 18 / Zacks.com
BioLineRx (BLRX) Looks Good: Stock Moves 9.1% Higher - Tale of the Tape
Mar 25 / Zacks.com
Esperion Therapeutics (ESPR) Jumps: Stock Rises 29.2% - Tale of the Tape
Mar 18 / Zacks.com
Zafgen (ZFGN) Crumbles: Stock Falls by 7.9% - Tale of the Tape
Mar 25 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account